Nature Communications (Dec 2023)

NEMO reshapes the α-Synuclein aggregate interface and acts as an autophagy adapter by co-condensation with p62

  • Nikolas Furthmann,
  • Verian Bader,
  • Lena Angersbach,
  • Alina Blusch,
  • Simran Goel,
  • Ana Sánchez-Vicente,
  • Laura J. Krause,
  • Sarah A. Chaban,
  • Prerna Grover,
  • Victoria A. Trinkaus,
  • Eva M. van Well,
  • Maximilian Jaugstetter,
  • Kristina Tschulik,
  • Rune Busk Damgaard,
  • Carsten Saft,
  • Gisa Ellrichmann,
  • Ralf Gold,
  • Arend Koch,
  • Benjamin Englert,
  • Ana Westenberger,
  • Christine Klein,
  • Lisa Jungbluth,
  • Carsten Sachse,
  • Christian Behrends,
  • Markus Glatzel,
  • F. Ulrich Hartl,
  • Ken Nakamura,
  • Chadwick W. Christine,
  • Eric J. Huang,
  • Jörg Tatzelt,
  • Konstanze F. Winklhofer

DOI
https://doi.org/10.1038/s41467-023-44033-0
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 24

Abstract

Read online

Abstract NEMO is a ubiquitin-binding protein which regulates canonical NF-κB pathway activation in innate immune signaling, cell death regulation and host-pathogen interactions. Here we identify an NF-κB-independent function of NEMO in proteostasis regulation by promoting autophagosomal clearance of protein aggregates. NEMO-deficient cells accumulate misfolded proteins upon proteotoxic stress and are vulnerable to proteostasis challenges. Moreover, a patient with a mutation in the NEMO-encoding IKBKG gene resulting in defective binding of NEMO to linear ubiquitin chains, developed a widespread mixed brain proteinopathy, including α-synuclein, tau and TDP-43 pathology. NEMO amplifies linear ubiquitylation at α-synuclein aggregates and promotes the local concentration of p62 into foci. In vitro, NEMO lowers the threshold concentrations required for ubiquitin-dependent phase transition of p62. In summary, NEMO reshapes the aggregate surface for efficient autophagosomal clearance by providing a mobile phase at the aggregate interphase favoring co-condensation with p62.